KNSA vs. MU
KNSA (Kiniksa Pharmaceuticals, Ltd.) and MU (Micron Technology, Inc.) are both stocks. KNSA operates in Biotechnology (Healthcare), while MU operates in Semiconductors (Technology). Over the past 5 years, KNSA returned 34.30%/yr vs 66.39%/yr for MU. At a 0.18 correlation, their price movements are largely independent.
Performance
KNSA vs. MU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KNSA achieves a 53.79% return, which is significantly lower than MU's 243.32% return.
KNSA
- 1D
- -2.97%
- 1M
- 22.99%
- 6M
- 48.68%
- YTD
- 53.79%
- 1Y
- 125.85%
- 3Y*
- 65.48%
- 5Y*
- 34.30%
- 10Y*
- —
MU
- 1D
- -1.24%
- 1M
- -1.65%
- 6M
- 183.94%
- YTD
- 243.32%
- 1Y
- 687.66%
- 3Y*
- 149.71%
- 5Y*
- 66.39%
- 10Y*
- 54.18%
KNSA vs. MU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
KNSA Kiniksa Pharmaceuticals, Ltd. | 53.79% | 108.54% | 12.77% | 17.09% | 27.27% | -33.39% | 59.76% | -60.63% | 14.89% |
MU Micron Technology, Inc. | 243.32% | 240.24% | -0.96% | 71.93% | -45.93% | 24.21% | 39.79% | 69.49% | -47.09% |
Correlation
The correlation between KNSA and MU is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since May 24, 2018 | 0.18 |
The correlation between KNSA and MU shifts across timeframes, from 0.09 (1 year) to 0.20 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
KNSA:
$4.77B
MU:
$1.11T
KNSA:
$0.92
MU:
$44.42
KNSA:
69.30
MU:
22.05
KNSA:
0.67
MU:
0.08
KNSA:
6.71
MU:
12.33
KNSA:
8.63
MU:
11.10
KNSA:
$754.05M
MU:
$90.27B
KNSA:
$294.06M
MU:
$65.51B
KNSA:
$101.06M
MU:
$44.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KNSA vs. MU — Risk / Return Rank
KNSA
MU
KNSA vs. MU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kiniksa Pharmaceuticals, Ltd. (KNSA) and Micron Technology, Inc. (MU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KNSA | MU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -6.60 | ||
| Sortino ratioReturn per unit of downside risk | -1.72 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.69 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | 5.67 | 23.23 | -17.56 |
| Martin ratioReturn relative to average drawdown | 20.16 | 83.25 | -63.10 |
Loading charts...
Drawdowns
KNSA vs. MU - Drawdown Comparison
The maximum KNSA drawdown since its inception was -83.06%, smaller than the maximum MU drawdown of -98.25%. Use the drawdown chart below to compare losses from any high point for KNSA and MU.
Loading charts...
Drawdown Indicators
| KNSA | MU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.06% | -98.25% | +15.19% |
Max Drawdown (1Y)Largest decline over 1 year | -21.12% | -30.28% | +9.16% |
Max Drawdown (3Y)Largest decline over 3 years | -34.14% | -57.63% | +23.49% |
Max Drawdown (5Y)Largest decline over 5 years | -53.17% | -57.63% | +4.46% |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.63% | — |
Current DrawdownCurrent decline from peak | -5.72% | -19.29% | +13.57% |
Average DrawdownAverage peak-to-trough decline | -40.34% | -58.07% | +17.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.94% | 8.43% | -2.49% |
Volatility
KNSA vs. MU - Volatility Comparison
The current volatility for Kiniksa Pharmaceuticals, Ltd. (KNSA) is 14.13%, while Micron Technology, Inc. (MU) has a volatility of 33.63%. This indicates that KNSA experiences smaller price fluctuations and is considered to be less risky than MU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KNSA | MU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.13% | 33.63% | -19.50% |
Volatility (6M)Calculated over the trailing 6-month period | 35.91% | 62.19% | -26.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.41% | 75.68% | -31.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.62% | 54.75% | -1.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.89% | 50.65% | +13.24% |
Dividends
KNSA vs. MU - Dividend Comparison
KNSA has not paid dividends to shareholders, while MU's dividend yield for the trailing twelve months is around 0.05%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
KNSA Kiniksa Pharmaceuticals, Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MU Micron Technology, Inc. | 0.05% | 0.16% | 0.55% | 0.54% | 0.89% | 0.21% |
Financials
KNSA vs. MU - Financials Comparison
This section allows you to compare key financial metrics between Kiniksa Pharmaceuticals, Ltd. and Micron Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KNSA vs. MU - Profitability Comparison
KNSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.
MU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Micron Technology, Inc. reported a gross profit of 35.06B and revenue of 41.46B. Therefore, the gross margin over that period was 84.6%.
KNSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.
MU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Micron Technology, Inc. reported an operating income of 33.31B and revenue of 41.46B, resulting in an operating margin of 80.4%.
KNSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.
MU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Micron Technology, Inc. reported a net income of 28.24B and revenue of 41.46B, resulting in a net margin of 68.1%.
Frequently Asked Questions
KNSA and MU have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MU has higher volatility (33.63%) compared to KNSA (14.13%). In terms of maximum drawdown, KNSA dropped -83.06% vs MU's -98.25%.
MU currently has the higher Sharpe Ratio (9.29 vs 2.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KNSA and MU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer